Barentine, Andrew E. S.
Lin, Yu
Courvan, Edward M.
Kidd, Phylicia http://orcid.org/0000-0003-0308-5065
Liu, Miao
Balduf, Leonhard http://orcid.org/0000-0002-3519-7160
Phan, Timy
Rivera-Molina, Felix
Grace, Michael R.
Marin, Zach http://orcid.org/0000-0001-5341-9911
Lessard, Mark http://orcid.org/0000-0002-1927-2204
Rios Chen, Juliana
Wang, Siyuan http://orcid.org/0000-0001-6550-4064
Neugebauer, Karla M. http://orcid.org/0000-0002-3835-6761
Bewersdorf, Joerg http://orcid.org/0000-0002-4085-7020
Baddeley, David http://orcid.org/0000-0002-8134-1987
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (T32 GM008283, U01 DA047734, U01 DA047734, U01 DA047734, U01 DA047734, R01 GM118486, U01 DA047734, U01 DA047734, DP2 GM137414, R01 HG011245, 1R01NS128358-1, P30 DK045735, 1R01NS128358-1)
China Scholarship Council
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (U01 DA047734)
Article History
Received: 2 June 2022
Accepted: 2 February 2023
First Online: 13 March 2023
Competing interests
: J.B. discloses a financial interest in Bruker Corp. and Hamamatsu Photonics. All other authors declare no competing interests.